Evidence map›Paper›PMID 27754332›Full record

ArticleMolecules (Basel, Switzerland)2016

Tetrandrine Induces Apoptosis of Human Nasopharyngeal Carcinoma NPC-TW 076 Cells through Reactive Oxygen Species Accompanied by an Endoplasmic Reticulum Stress Signaling Pathway.

Ya-Jing Lin, Shu-Fen Peng, Meng-Liang Lin, Chao-Lin Kuo, Kung-Wen Lu, Ching-Lung Liao, Yi-Shih Ma, Fu-Shin Chueh, Kuo-Ching Liu, Fu-Shun Yu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Targeting the two-pore channel 2 in cancer progression and metastasis.Exploration of targeted anti-tumor therapy · 2022
    Review
  4. Review
  5. Review
  6. Tetrandrine Suppresses Human Brain Glioblastoma GBM 8401/Molecules (Basel, Switzerland) · 2021
    Article
  7. Review
  8. Article
  9. Review
  10. A critical review: traditional uses, phytochemistry, pharmacology and toxicology ofPhytochemistry reviews : proceedings of the Phytochemical Society of Europe · 2020
    Review
  11. Review
  12. Impact and Relevance of the Unfolded Protein Response in HNSCC.International journal of molecular sciences · 2019
    Review
  13. Article
  14. Insights into the Roles of Midazolam in Cancer Therapy.Evidence-based complementary and alternative medicine : eCAM · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ya-Jing LinDepartment of Biological Science and Technology, China Medical University, Taichung 40402, Taiwan. cathy263938@gmail.com.
Shu-Fen PengDepartment of Biological Science and Technology, China Medical University, Taichung 40402, Taiwan. sfpeng@mail.cmu.edu.tw.
Meng-Liang LinDepartment of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 40402, Taiwan. mllinsally@yahoo.com.tw.
Chao-Lin KuoDepartment of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 40402, Taiwan. clkuo@mail.cmu.edu.tw.
Kung-Wen LuCollege of Chinese Medicine, School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung 40402, Taiwan. prorna@mail.cmu.edu.tw.
Ching-Lung LiaoCollege of Chinese Medicine, School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung 40402, Taiwan. qbking@ms29.hinet.net.
Yi-Shih MaDepartment of Chinese Medicine, E-Da Hospital, Kaohsiung 82445, Taiwan. m2367591@ms25.hinet.net.
Fu-Shin ChuehDepartment of Health and Nutrition Biotechnology, Asia University, Wufeng, Taichung 41354, Taiwan. fushin@asia.edu.tw.
Kuo-Ching LiuDepartment of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 40402, Taiwan. kchliu@mail.cmu.edu.tw.
Fu-Shun YuSchool of Dentistry, China Medical University, Taichung 40402, Taiwan. fsyu@mail.cmu.edu.tw.
Jing-Gung ChungDepartment of Biological Science and Technology, China Medical University, Taichung 40402, Taiwan. jgchung@mail.cmu.edu.tw.
China Medical University · TWAsia University · TWE-Da Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nasopharyngeal carcinoma (NPC) is an epithelial malignancy of the head and neck and the incidence is higher in Southeast Asia. Tetrandrine (TET) is a bisbenzylisoquinoline alkaloid, a natural product, and exhibits biological activities including action against many human cancer cell lines. However, the molecular mechanism of TET-induced cell apoptosis in human NPC cells is still unclear. In the present study, we investigated TET-induced apoptotic cell death and associated possible signal pathways on human nasopharyngeal carcinoma NPC-TW 076 cells in vitro. Phase contrast microscopy was used to examine cell morphology and DAPI staining was used to examine chromatin condensation. Flow cytometry assay was used to measure total viable cells, cell cycle and sub-G₁ phase distribution, reactive oxygen species (ROS), Ca

Indexed as

Antineoplastic Agents, PhytogenicApoptosisBenzylisoquinolinesCarcinomaCell CycleCell Line, TumorCell SurvivalEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressGene Expression Regulation, NeoplasticHumansMembrane Potential, MitochondrialNasopharyngeal CarcinomaNasopharyngeal NeoplasmsReactive Oxygen SpeciesSignal TransductionAntineoplastic Agents, PhytogenicBenzylisoquinolinesEndoplasmic Reticulum Chaperone BiPHSPA5 protein, humanReactive Oxygen Speciestetrandrineapoptosisendoplasmic reticulum (ER) stressNPC-TW 076 cellsreactive oxygen species (ROS)tetrandrine (TET)

Identifiers

PMID27754332
PMCPMC6273859
OpenAlexW2531421656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.